ARCH Venture Fund IX, L.P.

Holdings History for Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 per share (LYEL)

Symbol
LYEL on Nasdaq
Investment type
Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned
36,597,716 shares
Security Ownership %
13%

Robert Nelsen ownership in Lyell Immunopharma, Inc. Common Stock, par value $0.0001 per share (LYEL)

14 Feb 2025 - Robert Nelsen has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 36,597,716 shares of Lyell Immunopharma, Inc. Common Stock, par value $0.0001 per share (LYEL). This represents 13% ownership of the company. This is the first filing by ARCH Venture Fund IX, L.P. disclosing ownership of Lyell Immunopharma, Inc. Common Stock, par value $0.0001 per share (LYEL).